PharmaOnco™ CHO-Tg(Mouse PD-L1//TCR Activator) Stable Cell Line, Single Clone (CAT#: ITS-0822-HMM193)

Creative Biolabs offers CHO-Tg(Mouse PD-L1//TCR Activator) stable cell line which the PD-L1 and TCR Activator gene stably expressed in CHO cells.

CHO-Tg(Mouse PD-L1//TCR Activator) stable cell line is a cell line that has been genetically engineered to overexpress both Mouse PD-L1 (Programmed Death-Ligand 1) and a TCR (T Cell Receptor) activator. This cell line can be used in research studies to investigate the interactions between PD-L1 and TCR signaling pathways, as well as to study the effects of manipulating these pathways on immune cell function and responses.

Consistent gene expression;
Reliability and reproducibility;

Functional assay

PD-L1//TCR Activator

Mouse

CHO

GenBank Accession #NM_008798

The PD-1 gene, also known as programmed cell death protein 1, is a gene that encodes a protein found on the surface of T cells and other immune cells. PD-1 plays a crucial role in regulating the immune response by inhibiting T cell activity and preventing autoimmunity. However, overexpression of PD-1 can also suppress the immune response against cancer cells, allowing tumors to evade detection and destruction by the immune system. Therapies targeting PD-1, such as checkpoint inhibitors, have been developed to block the interaction between PD-1 and its ligands, releasing the brakes on the immune response and helping the body's immune system to attack and eliminate cancer cells. These treatments have shown significant success in treating various types of cancer, including melanoma, lung cancer, and lymphoma.
TCR (T cell receptor) activators are compounds or molecules that stimulate the activation of T cells in the immune system. T cells play a crucial role in the immune response by recognizing and attacking infected cells or foreign invaders. TCR activators can enhance the ability of T cells to detect and eliminate harmful pathogens or cancer cells.